The State of Texas Attorney General Takes Legal Action Against Tylenol Manufacturers Concerning Autism Spectrum Allegations
The top legal official in Texas Ken Paxton is suing the producers of Tylenol, claiming the firms hid alleged dangers that the drug posed to children's cognitive development.
The court filing arrives a month after President Donald Trump promoted an unverified association between consuming acetaminophen - also known as acetaminophen - during pregnancy and autism in children.
Paxton is suing J&J, which once produced the drug, the sole analgesic approved for pregnant women, and the current manufacturer, which now manufacturers it.
In a official comment, he claimed they "misled consumers by making money from suffering and promoting medication without regard for the dangers."
The company says there is no credible evidence tying acetaminophen to autism spectrum disorder.
"These manufacturers deceived for years, intentionally threatening millions to increase profits," the attorney general, a Republican, stated.
The company stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the potential impact that could have on the well-being of American women and children."
On its online platform, Kenvue also said it had "consistently assessed the pertinent research and there is lacking reliable evidence that demonstrates a verified association between consuming acetaminophen and autism."
Organizations acting on behalf of physicians and healthcare providers concur.
The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in Tylenol - is one of the few options for expectant mothers to address pain and elevated temperature, which can create significant medical dangers if left untreated.
"In multiple decades of research on the use of paracetamol in gestation, no reliable research has successfully concluded that the usage of paracetamol in any period of gestation results in brain development issues in young ones," the group stated.
This legal action references latest statements from the former administration in asserting the medication is allegedly unsafe.
Last month, the former president generated worry from medical authorities when he advised pregnant women to "struggle intensely" not to take acetaminophen when sick.
The US Food and Drug Administration then published an announcement that doctors should contemplate reducing the usage of Tylenol, while also stating that "a direct connection" between the drug and autism in children has not been established.
The Health Department head Robert F Kennedy Jr, who oversees the FDA, had promised in spring to conduct "comprehensive study program" that would determine the source of autism in a matter of months.
But experts advised that finding a unique factor of autism spectrum disorder - believed by scientists to be the result of a intricate combination of genetic and surrounding conditions - would be difficult.
Autism spectrum disorder is a type of permanent neurological difference and condition that influences how individuals experience and relate to the surroundings, and is recognized using doctors' observations.
In his court filing, Paxton - a Trump ally who is campaigning for federal office - asserts Kenvue and J&J "deliberately disregarded and attempted to silence the research" around acetaminophen and autism.
The lawsuit attempts to require the corporations "remove any commercial messaging" that states acetaminophen is safe for expectant mothers.
The court case mirrors the complaints of a collection of guardians of young ones with autism and ADHD who took legal action against the manufacturers of Tylenol in recently.
Judicial authorities rejected the lawsuit, saying studies from the plaintiffs' authorities was inconclusive.